期刊文献+

环氧化酶-2表达在单磷酰脂A诱导的大鼠延迟性心肌保护中的作用 被引量:2

The role of COX-2 expression in the delayed phase of monophosphoryl lipid A preconditioning in myocardial ischemia-reperfusion in rats
原文传递
导出
摘要 目的探讨单磷酰脂 A(MLA)预处理对大鼠缺血再灌注心肌的影响及环氧化酶-2(COX-2)表达的作用。方法雄性 Wistar 大鼠24只分为4组:健康对照组(NC 组)、单纯缺血再灌注组(I/R 组)、单磷酰脂 A 预处理组(MLA-DP组)、单磷酰脂 A 预处理与 COX-2抑制剂 NS-398组(MLA+NS-398组);检测各组心功能、心肌梗死的范围;测定 MLA 预处理后24 h COX-2蛋白表达及心肌中前列腺素类化合物的含量。结果与 NC 组比较,MLA-DP 组心功能明显改善[左室内压峰值(LVSP)分别为:(124.1±12.0)mm Hg和(112.0±26.3)mm Hg,P<0.01],与 MLA-DP 组比较,MLA+NS-398组心功能下降(P<0.01)、心肌梗死范围增大[分别为(14±3)%和(32±9)%,P<0.01]。与 NC 组比较,MLA-DP 组 COX-2蛋白水平明显增加(P<0.01),心肌中前列腺素类化合物含量明显增加(P<0.01)。同 MLA-DP 组比较,MLA+NS 398组蛋白水平无明显变化,但MLA+NS-398组前列腺素类化合物含量明显减少(P<0.01)。结论 MLA 预处理适度上调了心肌细胞 COX-2蛋白表达,增加心肌前列腺素类化合物前列腺素 E_2的量,从而对大鼠缺血再灌注心肌有延迟保护作用。 Objective To determine whether monophosphoryl lipid A (MLA) could precondition rat heart and induce a cardioprotection by a mechanism involving the cyclooxygenase-2 (COX-2) activation. Methods Wistar rats were divided into four groups: (1) control group(NC group) ; (2) I/R group: the hearts were injected with vehicle, and 24 h later, the animals' hearts were subjected to a 30-min left coronary artery occlusion followed by a 120 min reperfusion(I/R) ; (3) MLA-P group: the hearts were injected with MLA (450 g/kg, iv), then the following steps similar to (2); (4) MLA-kNS-398 group: the hearts were injected with MLA, 35 min before I/R , the hearts were injected with NS-398, a selective COX-2 inhibitor, then similar to (2). At the end of reperfusion, the myocardial contractile function and the myocardial infarct size were detected. The myocardial COX-2 protein expression after 24 h of treatment, the myocardial content of prostaglandin(PG)E2 and 6-keto-PGF1. were detected after 24 h of treatment. Results Compared with NC group,the MLA-P group had the improved myocardial contractile function(LVSP, ±dp/dt max)(P〈0.01 ), the reduced infarct size (P〈 0.01 ), the elevated expression of COX-2 protein (P〈 0.01 ), increased myocardial content of PGs(P〈0.01). Compared with MLA-P group,the MLA+NS-398 group had the decreased myocardial contractile function (LVSP.±dp/dt max)(P〈0. 01), the increased infarct size(P〈0. 01 ), not changed expression of COX-2 protein(P〉0.05), decreased myocardial content of PGs(P〈0. 01). Conclusions Monophosphoryl lipid A preconditioning can protect the heart. The up-regulation of COX-2 plays an essential role in the cardioprotection afforded by monophosphoryl lipid A preconditioning against myocardial ischaemic reperfusion.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2006年第2期137-140,共4页 Chinese Journal of Geriatrics
基金 湖北省教育厅2004年科研基金资助优秀中青年项目(2004Q002)
关键词 氧化还原酶类 缺血预处理 心肌 心肌再灌注损伤 Oxidoreductases Ischemic preconditioning, myocardial Myocardial reperfusion injury
  • 相关文献

参考文献8

  • 1Raberto BL. The late phase of preconditioning.Circulation Research. 2000,87:972-982.
  • 2Peng J, Lu R. Deng HW. et al. Involvernent of alphecalcitonin gene-relaled peptide in monophosphoryl lipid A-induced delayed preconditioning in rat hearts. Eur J Pharmacol,2002,436 : 89-96.
  • 3Q Li. Gua Y, Xuan YT et al. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyelooxygenase-2- dependent mechanism. Cite Res,2003,92:741 - 748.
  • 4程芳洲,唐国华,李庚山,余细球,李远重,贺新华,鲍翠玉,周云.去甲肾上腺素和缺血预处理对大鼠缺血再灌注心肌细胞凋亡、Bcl-2、Bax蛋白表达的影响[J].中国病理生理杂志,2002,18(8):949-952. 被引量:11
  • 5Nogawa S, Forster C, Zhang F, et al. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA, 1998,95:10966-10971.
  • 6Shinmura K, Tang XL, Wang Y, et al. Cyclooxygenase-2 mediates the cardioprotectlve effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA, 2000, 97: 10197-10202.
  • 7Xi L, Tekin D, Gursoy E, et al. Evidence that NOS2acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol, 2002,283 : 5-12.
  • 8Degousee J, Martindale E, Stefanski M, et al. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo. Circ Res, 2003, 92: 757-764.

二级参考文献4

共引文献10

同被引文献13

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部